n-succinimidyl-3-(tri-n-butylstannyl)benzoate has been researched along with Glial Cell Tumors in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bigner, DD; Garg, PK; Schuster, JM; Zalutsky, MR | 1 |
Bigner, DD; Colapinto, EV; Garg, PK; Noska, MA; Zalutsky, MR | 1 |
2 other study(ies) available for n-succinimidyl-3-(tri-n-butylstannyl)benzoate and Glial Cell Tumors
Article | Year |
---|---|
Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Topics: Animals; Antibodies, Monoclonal; Benzoates; Cell Adhesion Molecules, Neuronal; Cell Line; Extracellular Matrix Proteins; Glioma; Humans; Immunotherapy; Iodine Radioisotopes; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tenascin; Tissue Distribution; Transplantation, Heterologous; Trialkyltin Compounds | 1991 |
Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
Topics: Animals; Antibodies, Monoclonal; Benzoates; Cell Adhesion Molecules, Neuronal; Glioma; Immunoglobulin G; Immunotoxins; Iodine Radioisotopes; Mice; Mice, Nude; Neoplasms, Experimental; Radiation Dosage; Tenascin; Tissue Distribution; Trialkyltin Compounds | 1989 |